S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
GE   7.04 (-11.34%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
GE   7.04 (-11.34%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
GE   7.04 (-11.34%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
GE   7.04 (-11.34%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
Log in

NYSE:STE - Steris Stock Price, Forecast & News

$137.70
-2.27 (-1.62 %)
(As of 04/1/2020 04:00 PM ET)
Today's Range
$133.79
Now: $137.70
$140.03
50-Day Range
$107.76
MA: $148.77
$168.51
52-Week Range
$105.69
Now: $137.70
$168.98
Volume1.04 million shs
Average Volume758,561 shs
Market Capitalization$11.68 billion
P/E Ratio29.93
Dividend Yield1.06%
Beta0.8
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment install, maintain, upgrade, repair, and troubleshoot services. This segment provides its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, including instrument and endoscope repair and maintenance solutions; and custom process improvement consulting and outsourced sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier products, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization services using gamma, electron beam, and X-ray technologies, as well as ethylene oxide and hydrogen peroxide; and laboratory testing services. It operates a network of approximately 50 facilities. The company was founded in 1985 and is based in Derby, the United Kingdom.
Read More
Steris logo

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP85915210
Phone353-1232-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.78 billion
Cash Flow$7.48 per share
Book Value$37.66 per share

Profitability

Net Income$304.05 million

Miscellaneous

Employees12,000
Market Cap$11.68 billion
Next Earnings Date5/11/2020 (Estimated)
OptionableOptionable

Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.


Steris (NYSE:STE) Frequently Asked Questions

How has Steris' stock been impacted by COVID-19 (Coronavirus)?

Steris' stock was trading at $145.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, STE shares have decreased by 5.2% and is now trading at $137.70. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Steris?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Steris.

When is Steris' next earnings date?

Steris is scheduled to release its next quarterly earnings announcement on Monday, May 11th 2020. View our earnings forecast for Steris.

How were Steris' earnings last quarter?

Steris PLC (NYSE:STE) announced its quarterly earnings results on Monday, February, 10th. The medical equipment provider reported $1.45 EPS for the quarter, beating analysts' consensus estimates of $1.42 by $0.03. The medical equipment provider earned $774.30 million during the quarter, compared to analysts' expectations of $748.45 million. Steris had a net margin of 13.21% and a return on equity of 16.33%. The business's quarterly revenue was up 11.2% compared to the same quarter last year. During the same period in the previous year, the company posted $1.26 earnings per share. View Steris' earnings history.

How often does Steris pay dividends? What is the dividend yield for Steris?

Steris declared a quarterly dividend on Monday, February 10th. Shareholders of record on Tuesday, February 25th will be paid a dividend of $0.37 per share on Thursday, March 26th. This represents a $1.48 dividend on an annualized basis and a dividend yield of 1.07%. The ex-dividend date is Monday, February 24th. View Steris' dividend history.

What guidance has Steris issued on next quarter's earnings?

Steris issued an update on its FY 2020 After-Hours earnings guidance on Monday, February, 10th. The company provided earnings per share guidance of 5.65-5.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.57.

What price target have analysts set for STE?

4 Wall Street analysts have issued twelve-month price targets for Steris' stock. Their forecasts range from $138.00 to $150.00. On average, they anticipate Steris' share price to reach $144.33 in the next year. This suggests a possible upside of 4.8% from the stock's current price. View analysts' price targets for Steris.

Has Steris been receiving favorable news coverage?

News headlines about STE stock have been trending very negative this week, according to InfoTrie Sentiment. The research firm scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Steris earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutSteris.

Are investors shorting Steris?

Steris saw a decline in short interest in the month of March. As of March 13th, there was short interest totaling 1,275,100 shares, a decline of 18.8% from the February 27th total of 1,570,000 shares. Based on an average trading volume of 881,000 shares, the days-to-cover ratio is currently 1.4 days. Approximately 1.5% of the shares of the stock are short sold. View Steris' Current Options Chain.

Who are some of Steris' key competitors?

What other stocks do shareholders of Steris own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Johnson & Johnson (JNJ), Mastercard (MA), AbbVie (ABBV), Mcdonald's (MCD), Gilead Sciences (GILD), Allergan (AGN), Pfizer (PFE), Stryker (SYK), AT&T (T) and Zimmer Biomet (ZBH).

Who are Steris' key executives?

Steris' management team includes the following people:
  • Mr. Walter M. Rosebrough Jr., CEO & Pres (Age 65)
  • Mr. Michael J. Tokich, Sr. VP, CFO & Director (Age 50)
  • Mr. Daniel A. Carestio, Chief Operating Officer (Age 46)
  • Mr. John Adam Zangerle, Sr. VP, Gen. Counsel, Sec. & Director (Age 52)
  • Dr. Adrian Vincent Coward, Sr. VP of Healthcare Specialty Services (Age 49)

What is Steris' stock symbol?

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

How do I buy shares of Steris?

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Steris' stock price today?

One share of STE stock can currently be purchased for approximately $137.70.

How big of a company is Steris?

Steris has a market capitalization of $11.68 billion and generates $2.78 billion in revenue each year. The medical equipment provider earns $304.05 million in net income (profit) each year or $4.89 on an earnings per share basis. Steris employs 12,000 workers across the globe. View additional information about Steris.

What is Steris' official website?

The official website for Steris is http://www.steris.com/.

How can I contact Steris?

Steris' mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]


MarketBeat Community Rating for Steris (NYSE STE)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  273 (Vote Outperform)
Underperform Votes:  380 (Vote Underperform)
Total Votes:  653
MarketBeat's community ratings are surveys of what our community members think about Steris and other stocks. Vote "Outperform" if you believe STE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/1/2020 by MarketBeat.com Staff

Featured Article: SEC Filing

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel